Shifting Paradigms in Glaucoma Therapy: Advances in Medications, Lasers, and Surgery
This course reviews growing clinical data and real-world evidence that support a variety of initial treatments for glaucoma, including sustained release medi
Related Articles
From the Editor: Balancing Quality of Life and Glaucoma
This is the journey of modern-day glaucoma treatment, recognizing that each patient has unique personal and disease characteristics and learning to do the best for…
Phakic intraocular lens exchange due to severe… : JCRS Online Case Reports
n. Patient and Clinical Findings: A 22-year-old woman was submitted to Artiflex implantation for the correction of myopia. Three months postoperatively, a severe anterior segment…
International Ophthalmology Residents’ Perspectives on Their Training Programs
Dr. Rachel Simpson interviews Dr. Alec Bernard, along with 4 of his institutional research partners, about findings presented at this year’s Global Ophthalmology Summit on…
Study explores the true costs of treating pediatric cataracts
Analysis highlights discrepancies between adult, pediatric cataract procedures.
AlloVir, Kalaris Announce Plans to Merge
PentaVision is an independent company dedicated to eye care professionals. More about our magazines, newsletters, conferences, education and other services at pentavisionmedia.com.
8 Highlights and Lessons From My First Annual Meeting
Over the years, I found myself turning to Academy resources as I pursued my own path in ophthalmology. So, attending and presenting at my first…
The Dry Eye Ménage-a-Trois: Sex, Hormones, and Cosmetics
Ocular surface experts Rachna Murthy, Amy Gallant Sullivan, and David A. Sullivan outline the link between menopause and dry eye disease. Read more at The…
Cerebral visual impairment is a growing concern in pediatric vision loss
NEI Initiative aims to boost awareness, standardize diagnosis, and improve care for children with CVI through multidisciplinary collaboration and emerging technologies.
Harrow announces expanded market access for cyclosporine ophthalmic solution in 2025 Medicare Part D Program
Harrow announced that starting in January 2025, Vevye will be covered under key Medicare Part D formularies and across major insurance programs, expanding access to…
Knowledge of Glaucoma Among New Patients to a Tertiary Eye… : Journal of Glaucoma
roughout the healthcare system. Purpose: To investigate the depth of knowledge about glaucoma among patients who were referred to a tertiary eye hospital for their…
